Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jun;7(2):63-6.

Correlation between Hormonal Statuses and Metabolic Syndrome in Postmenopausal Women

Saeideh Ziaei  1 , Hajar Mohseni  1
Affiliations

Correlation between Hormonal Statuses and Metabolic Syndrome in Postmenopausal Women

Saeideh Ziaei et al. J Family Reprod Health. 2013 Jun.

Abstract

Objective: To compare the hormonal status in postmenopausal women with and without metabolic syndrome.

Materials and methods: In this cross sectional study 110 postmenopausal women were enrolled. Participants completed a questionnaire and underwent a medical exam and serum evaluation for serum lipids including cholesterol (Chol), high density lipoprotein cholesterol (HDL), low density lipoprotein (LDL), triglyceride (TG), fasting blood sugar (FBS), sex hormone binding globulin (SHBG), estradiol and testosterone. Metabolic syndrome was defined according to the definition of the National Cholesterol Education Program- Adult Treatment Panel III. In this study P value less than 0.05 was accepted as significant.

Results: There were significant differences between the two groups of participants with and without metabolic syndrome in age, years after menopause, BMI, weight, SHBG and testosterone (p< 0.01).

Conclusion: SHBG and testosterone are the most significant correlated factors to metabolic syndrome in postmenopausal women.

Keywords: hormonal status; metabolic syndrome; postmenopausal women.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cameron A. The metabolic syndrome: Validity and utility of clinical definitions for cardiovascular disease and diabetes risk prediction. Maturitas. 2010;65:117–21. - PubMed
    1. Ding QF, Hayashi T, Zhang XJ, Funami J, Ge L, Li J, Huang XL, et al. Risks of CHD identified by different criteria of metabolic syndrome and related changes of adipocytokines in elderly postmenopusal women. Journal of Diabetes and Its Complications. 2007;21:315–19. - PubMed
    1. Martínez MA, Puig JG, Mora M, Aragón R, O'Dogherty P, Antón JL, et al. Metabolic syndrome: prevalence, associated factors, and C- reactive protein. The MADRIC ( MADrid RIesgo Cardiovascular) Study. Metabolism clinical and Exprimental. 2008;57:1232–40. - PubMed
    1. Gaspard U. Hyperinsulinaemia, a key factor of The metabolic syndrome in postmenopausal women. Maturitas. 2009;62:362–5. - PubMed
    1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults(Adult Treatment Panel III) JAMA. 2003;285:2486–97. - PubMed

LinkOut - more resources